Clinical Trial Update: 'Effect of CRT on Defibrillation Threshold Estimates' Study [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of cardiac resynchronization therapy on defibrillation threshold estimates; results have been posted following completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sudden Cardiac Death

Drugs mentioned

• Cardiac resynchronization therapy-defibrillator (CRT-D) device (cardiac resynchronization therapy with defibrillator)

Snippet

Sponsor: Abbott Medical Devices | Conditions: Sudden Cardiac Death | Phase 4 | Status: COMPLETED | Results posted: 2013-01-21